You have 9 free searches left this month | for more free features.

ESSPRI

Showing 1 - 25 of 75

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sjögren and Gynecologic Considerations

Completed
  • Primary Sjögren Syndrome
  • +3 more
  • Visual analogue scale (VAS) for dyspareunia
  • +3 more
  • Ankara, Turkey
    Ankara City Hospital
Jan 3, 2023

Dry Eye Syndrome, Xerophthalmia Trial (Acupuncture, Oral microbiota, Schirmer's test)

Recruiting
  • Dry Eye Syndrome
  • Xerophthalmia
  • Acupuncture
  • +14 more
  • Taipei, Taiwan
    Ching-Mao Chang
Dec 11, 2022

Sjogren's Syndrome, Fatigue, Pain Syndrome Trial in Yildirim (FACT-F questionnaire, Beck Depression Inventory, Beck Anxiety

Completed
  • Sjogren's Syndrome
  • +5 more
  • FACT-F questionnaire
  • +6 more
  • Yıldırım, Bursa, Turkey
    Koray Ayar
Nov 29, 2021

Objective Measurement With TCM Pattern for AIDDES

Recruiting
  • Sjögren's Syndrome
  • +2 more
  • Traditional Chinese Medicine pattern
  • +6 more
  • Taipei, Taiwan
    Ching-Mao Chang
May 4, 2021

Sjogren's Syndrome Trial in Beijing (Baricitinib, Hydroxychloroquine)

Recruiting
  • Sjogren's Syndrome
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 17, 2022

Sjogren's Syndrome Trial (Anifrolumab)

Recruiting
  • Sjogren's Syndrome
  • Groningen, Netherlands
    University Medical Centre Groningen
Dec 16, 2022

Sjogren's Syndrome Trial (Dazodalibep, Placebo)

Not yet recruiting
  • Sjogren's Syndrome
  • (no location specified)
Oct 23, 2023

Dry Eye Syndrome, Sjogren's Syndrome, Xerophthalmia Trial in Taipei (Chinese herbal tea VGH-DESJS-1)

Not yet recruiting
  • Dry Eye Syndrome
  • +2 more
  • Chinese herbal tea VGH-DESJS-1
  • Taipei, Taiwan
    Ching-Mao Chang
Dec 19, 2022

Primary Sjögren's Syndrome Trial (Efgartigimod, Placebo)

Not yet recruiting
  • Primary Sjögren's Syndrome
  • Efgartigimod
  • Placebo
  • (no location specified)
Apr 5, 2023

Sjogrens Syndrome Trial (Ianalumab (VAY736), Placebo)

Not yet recruiting
  • Sjogrens Syndrome
  • Ianalumab (VAY736)
  • Placebo
  • (no location specified)
Aug 3, 2023

Sjogren Syndrome With Other Organ Involvement Trial (Hydroxychloroquine, Tacrolimus)

Not yet recruiting
  • Sjogren Syndrome With Other Organ Involvement
  • (no location specified)
Dec 28, 2022

Sjogren Syndrome With Other Organ Involvement Trial (Prednisolone, Tacrolimus)

Not yet recruiting
  • Sjogren Syndrome With Other Organ Involvement
  • (no location specified)
Jan 12, 2023

Primary Sjögren Syndrome Trial in Rochester (Ustekinumab)

Completed
  • Primary Sjögren Syndrome
  • Rochester, New York
    University of Rochester
Jul 6, 2022

Sjögren's Syndrome Trial in Worldwide (Deucravacitinib, Placebo)

Not yet recruiting
  • Sjögren's Syndrome
  • Santa Monica, California
  • +25 more
Jul 19, 2023

Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))

Withdrawn
  • Primary Sjogren's Syndrome
  • tibulizumab (LY3090106)
  • Palo Alto, California
    Stanford University
Jan 12, 2022

Primary Sjögren's Syndrome Trial in Hangzhou (Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets)

Recruiting
  • Primary Sjögren's Syndrome
  • Iguratimod Tablets
  • Hydroxychloroquine Sulfate Tablets
  • Hangzhou, Zhejiang, China
    Second affiliated hospital of zhejiang university,school of medi
Mar 23, 2022

Intestinal Microbiota in Gougerot-Sjögren Syndrome According to

Recruiting
  • Sjogren's Syndrome
  • Biomarker detection
  • Nîmes, France
    CHU de Nimes
May 24, 2022

Sjogren's Syndrome Trial in Worldwide (Placebo, Nipocalimab, Standard of Care Treatment)

Recruiting
  • Sjogren's Syndrome
  • Placebo
  • +2 more
  • Anniston, Alabama
  • +77 more
Aug 18, 2022

Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)

Recruiting
  • Primary Sjögren's Syndrome
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022

Sjögren Syndrome, Sicca Syndrome Trial in São Paulo (N-acetylcysteine syrup, Placebo syrup)

Active, not recruiting
  • Sjögren Syndrome
  • Sicca Syndrome
  • N-acetylcysteine syrup
  • Placebo syrup
  • São Paulo, Sao Paulo, Brazil
  • +1 more
Jun 13, 2022

Primary Sjögren's Syndrome Trial in Worldwide (S95011 concentrate for solution for infusion, Placebo concentrate for solution

Active, not recruiting
  • Primary Sjögren's Syndrome
  • S95011 concentrate for solution for infusion
  • Placebo concentrate for solution for infusion
  • Beverly Hills, California
  • +27 more
Jan 13, 2023

Sjogren's Syndrome Trial in Beijing (Baricitinib 2 MG)

Completed
  • Sjogren's Syndrome
  • Baricitinib 2 MG
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 26, 2021

Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome

Completed
  • Small Fiber Neuropathy
  • Primary Sjögren Syndrome
  • cutaneous silent period (CSP) measurement
  • Istanbul, Pendik, Turkey
    Marmara University Pendik Education and Research Hospital
May 16, 2022

Sjögren's Syndrome Trial in Worldwide (SAR441344, Placebo)

Recruiting
  • Sjögren's Syndrome
  • DeBary, Florida
  • +38 more
Dec 29, 2022

Sjogren Syndrome, Mixed Connective Tissue Disease Trial in Worldwide (MHV370, Placebo)

Recruiting
  • Sjogren Syndrome
  • Mixed Connective Tissue Disease
  • Guangzhou, Guangdong, China
  • +18 more
Jul 29, 2022